Results 101 to 110 of about 477,894 (133)

Improved Automated Radiosynthesis of [¹⁸F]Dolutegravir: Toward Clinical Applications. [PDF]

ACS Omega
Huvelle S, Pinon A, Coulon C, Bonasera T, Chapon C, Naninck T, Le Grand R, Parry CM, Kuhnast B, Caillé F.   +9 more
europepmc   +1 more source

Amiodarone Therapy: Updated Practical Insights. [PDF]

J Clin Med
Șorodoc V, Indrei L, Dobroghii C, Asaftei A, Ceasovschih A, Constantin M, Lionte C, Morărașu BC, Diaconu AD, Șorodoc L.   +9 more
europepmc   +1 more source

Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases. [PDF]

J Transl Med
Ni B, Ye L, Zhang Y, Hu S, Lei W.
europepmc   +1 more source

N-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants. [PDF]

ACS Infect Dis
Mahajan PS, Smith SJ, Li M, Craigie R, Hughes SH, Zhao XZ, Burke TR.   +6 more
europepmc   +1 more source

In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae. [PDF]

Mar Drugs
Nosik MN, Krylova NV, Usoltseva RV, Surits VV, Kireev DE, Shchelkanov MY, Svitich OA, Ermakova SP.   +7 more
europepmc   +1 more source

Immunological Enigma: A Case Report of COVID-19 Survival in a Patient With Human Immunodeficiency Virus, Hepatitis C Virus, and Tuberculosis Co-infection. [PDF]

Cureus
Bozhkova M, Petrov S, Velyanova T, Stoycheva M, Murdjeva M.   +4 more
europepmc   +1 more source

Acute promyelocytic leukemia with additional chromosome abnormalities in a patient positive for HIV: A case report and literature review. [PDF]

Oncol Lett
Li XL, Li M, Wang LZ, Tian J, Shi ZW, Song K.   +5 more
europepmc   +1 more source

Raltegravir Potassium

Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy/
Dennis J. Cada, Terri Levien, Danial E. Baker   +2 more
semanticscholar   +4 more sources

A Facile Synthesis of Raltegravir Potassium—An HIV Integrase Inhibitor

Journal of Heterocyclic Chemistry, 2019
A facile, cost‐effective, and commercially viable synthesis of Raltegravir Potassium (1) has been developed from 2‐(1‐amino‐1‐methyl‐ethyl)‐N‐[(4‐fluorophenyl)methyl]‐1,6‐dihydro‐5‐hydroxy‐1‐methyl‐6‐oxo‐4‐pyrimidinecarboxamide (9) with high purity and in good yields.
Kishore Karumanchi, Gangadhara Bhima Shankar Nangi, Subba Reddy Danda, Ramadas Chavakula, Raghu Babu Korupolu, B. Kishore Babu   +5 more
semanticscholar   +4 more sources

Identification, Synthesis, and Strategy For Minimization of Potential Impurities Observed In Raltegravir Potassium Drug Substance

Organic Process Research & Development, 2012
Multiple sources of anticipated degradation and process impurities of raltegravir potassium drug substance observed during the laboratory optimization and later during its bulk synthesis are described in this article. The impurities were monitored by UPLC, and their structures are tentatively assigned on the basis of fragmentation patterns in LC–MS and
Gulabrao D. Patil, Siddheshwar W. Kshirsagar, Shivnath B. Shinde, Pankaj S. Patil, Mangesh S. Deshpande, Ashok Chaudhari, Swapnil P. Sonawane, Golak C. Maikap, Mukund K. Gurjar   +8 more
semanticscholar   +4 more sources